chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Arthritis
Clinical narrative: Painful arthritis in left hand; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the right arm on 29Mar2021 at 16:00 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to penicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9269) via an unspecified route of administration in the right arm on 01Mar2021 at 12:00 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. On 05Apr2021 at 00:00, the patient experienced painful arthritis in left hand, that he never had before. The event did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event painful arthritis in left hand was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Pain in extremity, Vaccination site erythema, Vaccination site mass
Clinical narrative: my arm, where the injection was placed had a red circle about the size of a quarter and had a lump; my arm, where the injection was placed had a red circle about the size of a quarter and had a lump; left upper arm where injection was administered started to hurt in the muscle and surrounding areas/the pain is still intense while sleeping; left upper arm where injection was administered started to hurt in the muscle and surrounding areas/the pain is still intense while sleeping; This is a spontaneous report from a contactable consumer. A 74-years-old male patient received  bnt162b2 (BNT162B2, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration, administered in Arm Left on 01Mar2021 at 11:30 as Dose 2, Single for covid-19 immunization. Medical history none, patient was in excellent condition. The patient's concomitant medications were not reported. Historical vaccination the patient received first dose of bnt162b2, administered in Arm Left on 08Feb2021 11:30 (at the age of 74-year-old) as dose 1, single for covid-19 immunisation with no adverse reaction. The patient was not received any vaccine in four weeks. The patient had no covid prior to vaccination nor been tested positive post vaccination. The patient had no known allergies.On 01Apr2021, after 4 weeks of 2nd Pfizer Covid 19 shot, the patient stated that his left upper arm where injection was administered started to hurt in the muscle and surrounding areas. Very painful when turning my arm in certain positions. Been like this for at least a month. Last week my arm, where the injection was placed had a red circle about the size of a quarter and had a lump. After 3 days later it was gone however, the pain is still intense while sleeping. Therapy for the events included taking 600 mg of ibproferon so he could sleep and Heat packs on upper left muscle area. On an unknown date, the patient had recovered from the events injection was placed had a red circle about the size of a quarter and had a lump while the outcome of the other events was not recovered.  No follow up attempts were possible; Information about lot/batch number cannot be obtained. No further information was expected.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Intermenstrual bleeding
Clinical narrative: Menstral cycle started 3days aftervaccine. "Im" have normal cycles and they begin the 1st week of each month. "Iv" never had a cycle mid month.; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the left arm on 15Apr2021 at 13:00 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient did not have allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18Apr2021, the patient experienced menstrual cycle started 3 days after vaccine. The patient had normal cycles and they begin the first week of each month and she never had a cycle in mid of the month. It was reported that it was unsure how long it would last as it was lighter than usual but still odd for her body. The patient did not receive any treatment for the event. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event menstrual cycle started 3 days after vaccine, she had normal cycles and they begin the first week of each month and she never had a cycle mid-month was resolving at the time of this report.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Confusional state, Dizziness, Feeling cold, Gait inability
Clinical narrative: Severe fever 102; Body so sore couldn't get out of bed.; Going to the restroom was almost impossible; Coldest I've ever been in my life.; Headache for three days straight.; Confusion; Dizziness; Sweat so much at night I had to drink electrolyte water to stay hydrated every half an hour.; Could not sleep what so ever.; This is a spontaneous report from a contactable consumer, the patient. A 24-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 17Apr2021 at 16:00 (at the age of 24-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient previously took paracetamol (TYLENOL) and experienced drug allergy. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included norethisterone (MINI PILL) for birth control, from an unknown date and unknown if ongoing. The patient previously the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 27Mar2021 at 13:00 (at the age of 24-years-old) as a single dose for COVID-19 immunisation. On 17Apr2021 at 22:00 the patient experienced severe fever 102 (unspecified units) and body so sore that she could not get out of bed. The patient reported that going to the restroom was almost impossible and was the coldest she had ever been in her life. She had a headache for three days straight, confusion and dizziness. The patient sweat so much at night she had to drink electrolyte water to stay hydrated every half an hour and could not sleep what so ever. The events did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of events. On 17Apr2021, the patient underwent body temperature test and the result was 102 (unspecified units). Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken for the reported events. The clinical outcome of the events severe fever 102, body so sore could not get out of bed, going to the restroom was almost impossible, feeling cold, headache, confusion, dizziness, sweating, and could not sleep what so ever was recovering at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Hyperhidrosis, Insomnia, Pain, Pyrexia
Clinical narrative: Severe fever 102; Body so sore couldn't get out of bed.; Going to the restroom was almost impossible; Coldest I've ever been in my life.; Headache for three days straight.; Confusion; Dizziness; Sweat so much at night I had to drink electrolyte water to stay hydrated every half an hour.; Could not sleep what so ever.; This is a spontaneous report from a contactable consumer, the patient. A 24-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 17Apr2021 at 16:00 (at the age of 24-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient previously took paracetamol (TYLENOL) and experienced drug allergy. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included norethisterone (MINI PILL) for birth control, from an unknown date and unknown if ongoing. The patient previously the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 27Mar2021 at 13:00 (at the age of 24-years-old) as a single dose for COVID-19 immunisation. On 17Apr2021 at 22:00 the patient experienced severe fever 102 (unspecified units) and body so sore that she could not get out of bed. The patient reported that going to the restroom was almost impossible and was the coldest she had ever been in her life. She had a headache for three days straight, confusion and dizziness. The patient sweat so much at night she had to drink electrolyte water to stay hydrated every half an hour and could not sleep what so ever. The events did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of events. On 17Apr2021, the patient underwent body temperature test and the result was 102 (unspecified units). Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken for the reported events. The clinical outcome of the events severe fever 102, body so sore could not get out of bed, going to the restroom was almost impossible, feeling cold, headache, confusion, dizziness, sweating, and could not sleep what so ever was recovering at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Chest pain, Dyspnoea, Swelling
Clinical narrative: Left armpit swollen and painful; Left armpit swollen and painful; Chest pain; Difficulty breathing; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 15Apr2021 at 13:15 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination.  The patient previously received cefaclor (CECLOR) and sulfamethoxazole/trimethoprim (SEPTRA) on an unspecified date, for an unknown indication and experienced drug allergy.. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 25Mar2021 at 12:45 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. On 15Apr2021 at 15:00, the patient experienced left armpit swollen and painful, beginning hours after injection and lasted at least 4 days (it was 4 days since injection and both pain and swelling had  persisted). On 15Apr2021, 8-9 hours after injection, the patient experienced chest pain and difficulty breathing that lasted for 36 hours. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chest pain and difficulty breathing was recovered on 17Apr2021 after the duration of 36 hours while the events left armpit swollen and painful was not recovered at the time of this report.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Dyspnoea, Fatigue, Headache, Nasal congestion
Clinical narrative: Extreme tiredness; Coughing; Headache; Runny nose; Stuffy nose; Short of breath; This is a spontaneous report from a non-contactable consumer, the patient. A 60-year-old non-pregnant female patient received the The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the left arm on an unknown date, as a single dose for COVID-19 immunisation and also received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on an unknown date, as a single dose for COVID-19 immunisation. Medical history and Concomitant medication was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient previously received ciprofloxacin (CIPRO) and neomycin sulfate; polymyxin b sulfate; gramicidin (NEOSPORIN) and experienced drug allergy. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in Apr2021, the patient experienced extreme tiredness, coughing, headache, runny nose, stuffy nose, short of breath and also reported that these symptoms where not present 3 days after first Dose. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19.  The clinical outcome of the events extreme tiredness, coughing, headache, runny nose, stuffy nose, short of breath was not recovered at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Rhinorrhoea
Clinical narrative: Extreme tiredness; Coughing; Headache; Runny nose; Stuffy nose; Short of breath; This is a spontaneous report from a non-contactable consumer, the patient. A 60-year-old non-pregnant female patient received the The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the left arm on an unknown date, as a single dose for COVID-19 immunisation and also received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on an unknown date, as a single dose for COVID-19 immunisation. Medical history and Concomitant medication was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient previously received ciprofloxacin (CIPRO) and neomycin sulfate; polymyxin b sulfate; gramicidin (NEOSPORIN) and experienced drug allergy. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in Apr2021, the patient experienced extreme tiredness, coughing, headache, runny nose, stuffy nose, short of breath and also reported that these symptoms where not present 3 days after first Dose. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19.  The clinical outcome of the events extreme tiredness, coughing, headache, runny nose, stuffy nose, short of breath was not recovered at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Chills, Dyspnoea, Flank pain
Clinical narrative: Upper right back pain; Like upper flank pain; Chills; Takes my breath away; This is a spontaneous report from a non-contactable nurse, the patient. A 43-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the left arm on 16Apr2021 at 19:00 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included ascorbic acid (VITAMIN C), vitamin b complex (B COMPLEX), magnesium (MANUFACTURER UNKNOWN), calcium (MANUFACTURER UNKNOWN) and multi (MANUFACTURER UNKNOWN); all for unknown indications from an unknown date and unknown if ongoing. The patient previously received amoxicillin (MANUFACTURER UNKNOWN) for unknown indication on an unknown date and experienced drug allergy. On 18Apr2021 at 19:00, 48 hours after vaccination, the patient experienced upper right back pain and it went bad overnight, worsening through day 3 post-vaccination. Like upper flank pain which takes the breath away and chills but no fever. It was reported that the patient might go to emergency room. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events upper right back pain, upper flank pain which takes the breath away and chills was not resolved at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Fatigue, Muscle spasms, Pyrexia, Tremor
Clinical narrative: Leg cramps; Shacking; Fever 102; Sever vomiting; Feeling very very fatigue; Swollen at the injection site; This is a spontaneous report from a contactable consumer. A 56-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the left arm on 18Apr2021 at 15:00 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. Medical history included diabetes, high blood pressure and high cholesterol; but all had been under control for 5 years. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient previously took levofloxacin (LEVAQUIN) and experienced drug allergy to LEVAQUIN antibiotic. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19Apr2021 at 05:00, the patient experienced leg cramps, shaking, fever 102 (units unspecified), severe vomiting, felt very very fatigue, swollen at the injection site. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events leg cramps, shaking, fever 102 (units unspecified), severe vomiting, felt very very fatigue, swollen at the injection site was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site swelling, Vomiting
Clinical narrative: Leg cramps; Shacking; Fever 102; Sever vomiting; Feeling very very fatigue; Swollen at the injection site; This is a spontaneous report from a contactable consumer. A 56-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the left arm on 18Apr2021 at 15:00 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. Medical history included diabetes, high blood pressure and high cholesterol; but all had been under control for 5 years. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient previously took levofloxacin (LEVAQUIN) and experienced drug allergy to LEVAQUIN antibiotic. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19Apr2021 at 05:00, the patient experienced leg cramps, shaking, fever 102 (units unspecified), severe vomiting, felt very very fatigue, swollen at the injection site. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events leg cramps, shaking, fever 102 (units unspecified), severe vomiting, felt very very fatigue, swollen at the injection site was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Malaise, Pain, Pain in extremity, Pyrexia
Clinical narrative: Very Sore upper left arm,; Body aches; Slight fever - 99.5; General feeling of unwellness; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on 17Apr2021 at 15:30 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma, high blood pressure (HBP), and ulcerative colitis (UC). The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient received unspecified concomitant medications. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER3783) via an unspecified route of administration in the left arm on 27Mar2021 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. On 18Apr2021 at 20:00 the patient experienced very sore upper left arm, body aches, slight fever 99.5 and general feeling of unwell. On same day the patient underwent body temperature test and the result was 99.5 (unspecified unit). The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sore upper left arm, body aches, slight fever 99.5 and general feeling of unwell were recovered on 19Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Body temperature fluctuation, Bone pain, Fatigue, Headache
Clinical narrative: Headache; Fatigue; Aching joints and bones; Aching joints and bones; Body temperature fluctuations; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 09Apr2021 at 12:30 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 12Mar2021 at 13:00 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. On 10Apr2021 at 14:00, the patient experienced headache, fatigue, aching joints and bones and body temperature fluctuations. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events headache, fatigue, aching joints and bones and body temperature fluctuations was recovered on an unknown date in Apr2021.No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Rash, Rash pruritic
Clinical narrative: Rash on the right side of my body; It was itchy then started burning.; Rash on the right side of my body, that started 1 wk after vaccination. It was itchy.; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the right arm on 31Mar2021 at 08:30 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. Medical history included polycystic ovarian syndrome (pcos). The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any concomitant medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021 at 04:00, the patient experienced a rash on the right side of her body, that started 1 week after vaccination. It was itchy then started burning. It looked like her skin was burned. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event rash on the right side of patient's body, itchy and skin was burned was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Erythema, Myalgia, Nausea, Pain
Clinical narrative: The second day i had injection site swelling the size of my cupped hand; Redness; Pain; Nauseous the entire night after my injection; The next morning every joint was in severe pain; The next morning every muscle was in severe pain; She couldn't fully close her fist due to swelling and all she wanted to do was sleep.; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER879) via an unspecified route of administration on 17Apr2021 at 12:45 (at the age of 55-year-old) as a single dose for COVID-19 immunisation. Medical history included covid-19 from Jan2021, pneumonia and known allergies to possible penicillin. Prior to vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included trazodone (MANUFACTURER UNKNOWN) from an unknown date for an unknown indication. On 17Apr2021, on the first day, the patient was ok. On 18Apr2021, the second day after vaccination, she had injection site swelling the size of her cupped hand. She also had redness and pain. She was nauseous the entire night after her injection. The next morning every joint and most on her muscles were in severe pain. She couldn't fully close her fist due to swelling and all she wanted to do was sleep. She called in sick the third day. She felt it would be dangerous to drive to work. The fourth day, she was much better. She had severe COVID-19 in January2021. She had pneumonia and was in hospital for a week. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events injection site swelling, redness, pain, nauseous, every joint and most on her muscles were in severe pain and couldn't fully close her fist due to swelling and all she wanted to do was sleep was recovering at the time of report.   No follow-up attempts are needed. No further information is expected.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Somnolence, Vaccination site swelling
Clinical narrative: The second day i had injection site swelling the size of my cupped hand; Redness; Pain; Nauseous the entire night after my injection; The next morning every joint was in severe pain; The next morning every muscle was in severe pain; She couldn't fully close her fist due to swelling and all she wanted to do was sleep.; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER879) via an unspecified route of administration on 17Apr2021 at 12:45 (at the age of 55-year-old) as a single dose for COVID-19 immunisation. Medical history included covid-19 from Jan2021, pneumonia and known allergies to possible penicillin. Prior to vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included trazodone (MANUFACTURER UNKNOWN) from an unknown date for an unknown indication. On 17Apr2021, on the first day, the patient was ok. On 18Apr2021, the second day after vaccination, she had injection site swelling the size of her cupped hand. She also had redness and pain. She was nauseous the entire night after her injection. The next morning every joint and most on her muscles were in severe pain. She couldn't fully close her fist due to swelling and all she wanted to do was sleep. She called in sick the third day. She felt it would be dangerous to drive to work. The fourth day, she was much better. She had severe COVID-19 in January2021. She had pneumonia and was in hospital for a week. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events injection site swelling, redness, pain, nauseous, every joint and most on her muscles were in severe pain and couldn't fully close her fist due to swelling and all she wanted to do was sleep was recovering at the time of report.   No follow-up attempts are needed. No further information is expected.
Age: 16.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Dyspnoea, Fatigue, Headache
Clinical narrative: Hurts to breathe; Tired; Headache; Joint aches; This is a spontaneous report from a contactable consumer, the patient. A 16-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration on 17Apr2021 (at the age of 16-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma and environmental allergy since unknown dates. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included salbutamol (ALBUTEROL) and loratadine (CLARITIN). The patient did not receive any other vaccines within four weeks prior to the vaccination.  On 19Apr2021, the patient experienced tiredness, headache, joint aches and it hurt to breathe. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events tired, headache, joint aches and hurts to breathe were not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Retinal migraine, SARS-CoV-2 test
Clinical narrative: Retinol migraine six days post vaccination followed by several days of extreme fatigue; Extreme fatigue; This is a spontaneous report from a contactable consumer, the patient. A 28-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 08Apr2021 at 11:30 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. Medical history included polycystic ovarian syndrome (PCOS). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient previously took rheum palmatum (RHUBARB) and doxycycline (MANUFACTURER UNKNOWN) and experienced drug allergy. Concomitant medication was not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021, the patient experienced retinol migraine six days post vaccination followed by several days of extreme fatigue. The event resulted in emergency room/department or urgent care. On 13Apr2021, the patient underwent SARS-CoV-2 test (nasal swab) and the result was pending. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had been tested for COVID-19. The clinical outcome of the event retinol migraine six days post vaccination followed by several days of extreme fatigue was resolved with sequelae On an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pruritus
Clinical narrative: Itchiness all over; Sore arm; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the right arm on 19Apr2021 at 15:30 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Medical history included hashimoto's, hypothyroidism, polycystic ovarian syndrome (PCOS), vitamin b12 deficiency and vitamin d deficiency. The patient had no known allergies to medications, food, or other products. Concomitant medications included paracetamol (TYLENOL), ibuprofen (MANUFACTURER UNKNOWN), levothyroxine sodium (UNITHROID), vitamin d nos (VIT D) and cyanocobalamin (B-12); all for an unknown indication from an unknown date and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19Apr2021 at 15:45, the patient experienced itchiness all over and sore arm. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events itchiness all over and sore arm were not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Migraine with aura
Clinical narrative: This is a spontaneous report from a contactable consumer (patient). A 27-year-old male patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# unknown), at the age of 27, via an unspecified route of administration, in the left arm, on Apr 14, 2021, at 19:00, single dose, for COVID-19 immunisation. Medical history and concomitant medications not reported. Prior to vaccination, patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On Apr 19, 2021, at 19:30, patient had a severe migraine with aura. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures taken as a result of the event and included treatment with ibuprofen 800mg. Since the vaccination, patient has not tested for COVID-19. The outcome of severe migraine with aura resolved with sequelae on an unknown date in Apr 2021. No follow-up attempts required. Information about batch/lot number cannot be obtained. No further information expected.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Body temperature, Chills, Fatigue, Myalgia
Clinical narrative: Muscle pain (not simply aches); Joint pain (not simply aches); 102 Fever; Extreme shaking chills; Extreme fatigue; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 01Apr2021 at 09:15(at the age of 64-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to two antibiotics and COVID-19. Prior to vaccination, the patient was diagnosed with COVID-19. Concomitant medications included simvastatin (MANUFACTURER UNKNOWN), ergocalciferol (VIT D), biotin (MANUFACTURER UNKNOWN), acetylsalicylic acid (ASPIRIN) and krill (MANUFACTURER UNKNOWN); all for unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On 01Apr2021, the patient experienced muscle and joint pain (not simply aches), 102 fever, extreme shaking chills (fever not present at that time) and extreme fatigue. On the same day, the patient underwent body temperature test and the result was 102 (units unspecified). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not tested for COVID-19. The clinical outcome of the events muscle and joint pain, 102 fever, extreme shaking chills and extreme fatigue was resolved on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Muscle pain (not simply aches); Joint pain (not simply aches); 102 Fever; Extreme shaking chills; Extreme fatigue; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 01Apr2021 at 09:15(at the age of 64-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to two antibiotics and COVID-19. Prior to vaccination, the patient was diagnosed with COVID-19. Concomitant medications included simvastatin (MANUFACTURER UNKNOWN), ergocalciferol (VIT D), biotin (MANUFACTURER UNKNOWN), acetylsalicylic acid (ASPIRIN) and krill (MANUFACTURER UNKNOWN); all for unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On 01Apr2021, the patient experienced muscle and joint pain (not simply aches), 102 fever, extreme shaking chills (fever not present at that time) and extreme fatigue. On the same day, the patient underwent body temperature test and the result was 102 (units unspecified). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not tested for COVID-19. The clinical outcome of the events muscle and joint pain, 102 fever, extreme shaking chills and extreme fatigue was resolved on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Chapped lips, Lip dry, Lip swelling, Rash
Clinical narrative: Swollen lips that have dried and cracked; Swollen lips that have dried and cracked; Swollen lips that have dried and cracked; become uncomfortable apparent skip rash/reaction around mouth, temple, back of knees and groin; This is a spontaneous report from a contactable other healthcare professional, the patient. A 49-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 13Apr2021 at 16:45 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Medical history included 1.5 functioning kidneys, double ureters on both and known allergy to penicillin, other antibiotics, red dye 40, gluten, bananas and other food sensitives. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not take any concomitant medication. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 16Apr2021, the patient experienced swollen lips that have dried and cracked and become uncomfortable apparent skip rash/reaction around mouth, temple, back of knees and groin. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events swollen lips that have dried and cracked and become uncomfortable apparent skip rash/reaction around mouth, temple, back of knees and groin was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Heavy menstrual bleeding, Hypoaesthesia, Lip disorder, Menstrual disorder
Clinical narrative: Started period 4/20/21. It is extremely heavy; Started period 4/20/21. It is extremely heavy and completely abnormal for me.; Felt like heavy menstrual cramps continually from 4/10/21 to 4/20/21; My face went numb 20 minutes after the shot.; Had arm pain for a day; Extreme fatigue; The inside of the mouth is swollen; There is a bumpy texture on the inside of  the lip.; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 09Apr2021 at 09:30 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient had no known allergies to medications, food or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The patient did not receive any other medicines within two weeks prior to the COVID-19 vaccine. On 09Apr2021 at 09:50 (also reported as 09:45) 20 minutes after the shot the patient's face went numb. The patient had arm pain for a day. The patient experienced extreme fatigue, the inside of the mouth was swollen and there was a bumpy texture on the inside of the lip. On 10Apr2021, the patient experienced what felt like heavy menstrual cramps continually from 10Apr2021 to 20Apr2021. On 20Apr2021, the patient had period. It was extremely heavy and completely abnormal for the patient. The events did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events arm pain for a day was recovered on 10Apr2021 and felt like heavy menstrual cramps continually was recovered on 20Apr2021. The clinical outcome of the events face went numb 20 minutes after the shot, extreme fatigue, inside of the mouth was swollen, bumpy texture on the inside of the lip, started period, it was extremely heavy and completely abnormal was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Mouth swelling, Pain in extremity, Premenstrual pain
Clinical narrative: Started period 4/20/21. It is extremely heavy; Started period 4/20/21. It is extremely heavy and completely abnormal for me.; Felt like heavy menstrual cramps continually from 4/10/21 to 4/20/21; My face went numb 20 minutes after the shot.; Had arm pain for a day; Extreme fatigue; The inside of the mouth is swollen; There is a bumpy texture on the inside of  the lip.; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 09Apr2021 at 09:30 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient had no known allergies to medications, food or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The patient did not receive any other medicines within two weeks prior to the COVID-19 vaccine. On 09Apr2021 at 09:50 (also reported as 09:45) 20 minutes after the shot the patient's face went numb. The patient had arm pain for a day. The patient experienced extreme fatigue, the inside of the mouth was swollen and there was a bumpy texture on the inside of the lip. On 10Apr2021, the patient experienced what felt like heavy menstrual cramps continually from 10Apr2021 to 20Apr2021. On 20Apr2021, the patient had period. It was extremely heavy and completely abnormal for the patient. The events did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events arm pain for a day was recovered on 10Apr2021 and felt like heavy menstrual cramps continually was recovered on 20Apr2021. The clinical outcome of the events face went numb 20 minutes after the shot, extreme fatigue, inside of the mouth was swollen, bumpy texture on the inside of the lip, started period, it was extremely heavy and completely abnormal was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.